WELDON STEVEN W (CFO) received a stock award from GT BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/16/2019ACC: 0000939798-19-000030
DirectorOfficer10% Owner· CFO
Since Aug 2019
+4.50M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
4.50M acquired
Non-Derivative Transactions1
common stock
Direct
Shares
+4.50M
Price / share
—
Trade value
—
% of position
198.3%
8/14/2019
2.27M→6.77M
Total
Net shares
+4.50M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Direct | 8/14/2019 | A · Award | +4.50M | — | — | 198.3% | 2.27M | 6.77M |
| Total | +4.50M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported